bivalirudin
bivalirudin is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including Bivalirudin, bivalirudin. Available dosage forms: injection, powder, lyophilized, for solution, powder, injection, powder, lyophilized, for suspension.
Drug Details
- Generic Name
- bivalirudin
- Brand Names
- Bivalirudin, bivalirudin
- Application Number
- ANDA206551
- Sponsor
- Accord Healthcare, Inc.
- NDC Codes
- 9
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER, INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Routes
- INTRAVENOUS
- Active Ingredients
- BIVALIRUDIN
Indications and Usage
1 INDICATIONS AND USAGE Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Bivalirudin for Injection is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS). ( 1 )